These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 29533786)

  • 1. Tumor-Repopulating Cells Induce PD-1 Expression in CD8
    Liu Y; Liang X; Dong W; Fang Y; Lv J; Zhang T; Fiskesund R; Xie J; Liu J; Yin X; Jin X; Chen D; Tang K; Ma J; Zhang H; Yu J; Yan J; Liang H; Mo S; Cheng F; Zhou Y; Zhang H; Wang J; Li J; Chen Y; Cui B; Hu ZW; Cao X; Xiao-Feng Qin F; Huang B
    Cancer Cell; 2018 Mar; 33(3):480-494.e7. PubMed ID: 29533786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
    Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
    J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape.
    Zhang XY; Shi JB; Jin SF; Wang RJ; Li MY; Zhang ZY; Yang X; Ma HL
    Cancer Commun (Lond); 2024 Jun; 44(6):670-694. PubMed ID: 38734931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells.
    Liu Y; Liang X; Yin X; Lv J; Tang K; Ma J; Ji T; Zhang H; Dong W; Jin X; Chen D; Li Y; Zhang S; Xie HQ; Zhao B; Zhao T; Lu J; Hu ZW; Cao X; Qin FX; Huang B
    Nat Commun; 2017 May; 8():15207. PubMed ID: 28488695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icariside I - A novel inhibitor of the kynurenine-AhR pathway with potential for cancer therapy by blocking tumor immune escape.
    Chen G; Huang J; Lei H; Wu F; Chen C; Song Y; Cao Z; Zhang C; Zhang C; Ma Y; Huang M; Zhou J; Lu Y; Zhao Y; Zhang L
    Biomed Pharmacother; 2022 Sep; 153():113387. PubMed ID: 35834991
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Fong W; Li Q; Ji F; Liang W; Lau HCH; Kang X; Liu W; To KK; Zuo Z; Li X; Zhang X; Sung JJ; Yu J
    Gut; 2023 Nov; 72(12):2272-2285. PubMed ID: 37770127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.
    Campesato LF; Budhu S; Tchaicha J; Weng CH; Gigoux M; Cohen IJ; Redmond D; Mangarin L; Pourpe S; Liu C; Zappasodi R; Zamarin D; Cavanaugh J; Castro AC; Manfredi MG; McGovern K; Merghoub T; Wolchok JD
    Nat Commun; 2020 Aug; 11(1):4011. PubMed ID: 32782249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute exercise impacts AhR and PD-1 levels of CD8
    Schenk A; Joisten N; Walzik D; Koliamitra C; Schoser D; Bloch W; Zimmer P
    Eur J Appl Physiol; 2021 Feb; 121(2):637-644. PubMed ID: 33211154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells
    Amobi-McCloud A; Muthuswamy R; Battaglia S; Yu H; Liu T; Wang J; Putluri V; Singh PK; Qian F; Huang RY; Putluri N; Tsuji T; Lugade AA; Liu S; Odunsi K
    Front Immunol; 2021; 12():678999. PubMed ID: 34025677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor.
    Abuin-Martínez C; Vidal R; Gutiérrez-López MD; Pérez-Hernández M; Giménez-Gómez P; Morales-Puerto N; O'Shea E; Colado MI
    Neuropharmacology; 2021 Apr; 187():108490. PubMed ID: 33607146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tryptophan metabolite, kynurenine, promotes mast cell activation through aryl hydrocarbon receptor.
    Kawasaki H; Chang HW; Tseng HC; Hsu SC; Yang SJ; Hung CH; Zhou Y; Huang SK
    Allergy; 2014 Apr; 69(4):445-52. PubMed ID: 24397465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting epithelial-to-mesenchymal transition by D-kynurenine via activating aryl hydrocarbon receptor.
    Duan Z; Li Y; Li L
    Mol Cell Biochem; 2018 Nov; 448(1-2):165-173. PubMed ID: 29442266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer.
    Ding G; Shen T; Yan C; Zhang M; Wu Z; Cao L
    BMC Cancer; 2019 Nov; 19(1):1053. PubMed ID: 31694582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses.
    Beavis PA; Milenkovski N; Henderson MA; John LB; Allard B; Loi S; Kershaw MH; Stagg J; Darcy PK
    Cancer Immunol Res; 2015 May; 3(5):506-17. PubMed ID: 25672397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell Therapy.
    Kobold S; Grassmann S; Chaloupka M; Lampert C; Wenk S; Kraus F; Rapp M; Düwell P; Zeng Y; Schmollinger JC; Schnurr M; Endres S; Rothenfußer S
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26105028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenine Modulates MMP-1 and Type-I Collagen Expression Via Aryl Hydrocarbon Receptor Activation in Dermal Fibroblasts.
    Poormasjedi-Meibod MS; Salimi Elizei S; Leung V; Baradar Jalili R; Ko F; Ghahary A
    J Cell Physiol; 2016 Dec; 231(12):2749-60. PubMed ID: 26992058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
    Guo Z; Wang H; Meng F; Li J; Zhang S
    J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of proinflammatory monocyte activation by the kynurenine-AhR axis underlies immunometabolic control of depressive behavior in mice.
    Zang X; Zheng X; Hou Y; Hu M; Wang H; Bao X; Zhou F; Wang G; Hao H
    FASEB J; 2018 Apr; 32(4):1944-1956. PubMed ID: 29183965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenine-Induced Aryl Hydrocarbon Receptor Signaling in Mice Causes Body Mass Gain, Liver Steatosis, and Hyperglycemia.
    Rojas IY; Moyer BJ; Ringelberg CS; Wilkins OM; Pooler DB; Ness DB; Coker S; Tosteson TD; Lewis LD; Chamberlin MD; Tomlinson CR
    Obesity (Silver Spring); 2021 Feb; 29(2):337-349. PubMed ID: 33491319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1 Status in CD8
    Kansy BA; Concha-Benavente F; Srivastava RM; Jie HB; Shayan G; Lei Y; Moskovitz J; Moy J; Li J; Brandau S; Lang S; Schmitt NC; Freeman GJ; Gooding WE; Clump DA; Ferris RL
    Cancer Res; 2017 Nov; 77(22):6353-6364. PubMed ID: 28904066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.